BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20241010T110000
DTEND;TZID=UTC:20241010T120000
DTSTAMP:20260610T111759
CREATED:20240930T165834Z
LAST-MODIFIED:20241024T183125Z
UID:10000813-1728558000-1728561600@staging.digitalinsights.supremeclients.com
SUMMARY:Webinar: Streamline your hereditary diseases interpretation workflow with QCI Interpret
DESCRIPTION:Learn how QCI Interpret\, clinical decision support software for variant interpretation and reporting\, can help your lab rapidly identify pathogenic variants\, improve diagnostic yields\, and significantly reduce test turnaround time for hereditary diseases. Attendees will receive a demonstration of QCI Interpret’s unique capabilities and advanced features for germline variant interpretation with example workflows for carrier screening and whole-exome sequencing panels. Key highlights will include how your lab can expedite variant interpretation by leveraging the most extensive\, manually curated knowledge base\, dynamically compute pathogenicity based on ACMG guidelines for every variant with full transparency\, and leverage QCI Interpret’s proprietary augmented molecular intelligence approach to literature curation and variant classification to streamline your interpretation workflow. \nIn this webinar\, attendees will: \n\nReceive a demonstration of QCI Interpret’s analysis and interpretation workflows for hereditary diseases using targeted and extended gene panels\, including whole-genome and whole-exome sequencing.\nLearn about QIAGEN’s proprietary expert curation process for the knowledge base in QCI Interpret.\nExplore unique time-saving features within QCI Interpret\, including phenotype-driven ranking and automation of ACMG guidelines.\nUnderstand how QCI Interpret supports copy number variant (CNV) interpretation and reporting with bibliographic coverage of over 60\,000 CNV case reports.\n\n\n\n\nSpeaker: \n\n\n\n\nElias Hage\, PhD\nAssociate Director\, Global Product Management\nQIAGEN Digital Insights\n\n\nElias Hage\, PhD\, is the Associate Director of Global Product Management for Hereditary Disease and Oncology Applications at QIAGEN Digital Insights (QDI). In this role\, he oversees the development\, management\, and optimization of QDI software\, databases and services for genomic analysis and interpretation of hereditary disease and oncology cases. Prior to joining QDI\, Dr. Hage served as a Global Product Manager at Agilent Technologies\, where he managed the Genomics division flagship SaaS application (Alissa Interpret) and supported its usage globally in both research and IVD settings. Dr. Hage obtained his Ph.D. in virology and genomics from Hannover Medical School in Belgium.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/webinar-streamline-your-hereditary-diseases-interpretation-workflow-with-qci-interpret/
LOCATION:Virtual Global Event (Times shown in EST)
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1327_8_QDI_QCI_Hereditary_Gi1346512014.jpg
END:VEVENT
END:VCALENDAR